IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Asymmetry Capital Management, L.P.

Q4 2020 Holdings

Filed 2021-02-11 | 33 holdings | $28.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcus Biosciences Inc(RCUS)COM03969F109$9.0M348,40831.7%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$7.7M88,19527.1%
Codexis Inc(CDXS)COM192005106$7.0M318,49224.4%
C4 Therapeutics Inc(CCCC)COM12529R107$4.6M139,34316.2%
Viatris Inc(VTRS)COM92556V106$21.2K1,130,5040.1%
Sage Therapeutics Inc(SG7)COM78667J108$15.7K181,6500.1%
Jazz Pharmaceuticals PLC(JAZZ)COMG50871105$14.8K89,8890.1%
Insulet Corp(PODD)COM45784P101$11.7K45,6240.0%
Nanostring Technologies Inc(NSTGEUR)COM63009R109$11.6K172,8620.0%
Kura Oncology Inc(KURA)COM50127T109$11.3K346,5180.0%
Guardant Health Inc(GH)COM40131M109$10.2K79,2390.0%
Biodesix IncCOM09075X108$9.7K478,9850.0%
Fluidigm Corp(LAB)COM34385P108$9.3K1,544,9040.0%
Arena Pharmaceuticals Inc(ARNAEUR)COM040047607$7.8K101,2450.0%
Avadel Pharmaceuticals PLCADR05337M104$6.4K955,8560.0%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$5.9K96,5950.0%
10X Genomics Inc(TXG)COM88025U109$5.3K37,5870.0%
Burning Rock Biotech LTDADR12233L107$5.0K217,7280.0%
Iteos Therapeutics Inc(5E7)COM46565G104$4.7K138,3840.0%
Fate Therapeutics Inc(FATE)COM31189P102$4.6K50,7090.0%
Vistagen Therapeutics Inc(VTGNUSD)COM92840H202$4.3K2,239,8030.0%
Galecto Inc(GLTOUSD)COM36322Q107$4.2K337,3520.0%
Intra-Cellular Therapies Inc(ITCIEUR)COM46116X101$4.2K130,6540.0%
Bristol-Myers Squibb-Cvr(BMY-R)RTS110122157$3.6K5,152,0980.0%
Sutro Biopharma IncCOM869367102$3.4K157,5830.0%
Forte Biosciences Inc(TOCAEUR)COM34962G109$3.1K84,9890.0%
Nucana PLCADR67022C106$2.8K613,7690.0%
Mereo Biopharma Group PL(MREO)COM589492107$2.6K739,8120.0%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$2.3K67,2100.0%
Wave Life Sciences PTE LTD(WVE)COMY95308105$2.2K280,9240.0%
Novus Therapeutics IncCOM67011N105$1.2K80,0690.0%
Bcls Acquisition CorpCOMG0904B105$99389,1350.0%
Kalvista Pharmaceuticals Inc.(KALV)COM483497103$89146,9100.0%